In SEC Filing, J&J Says It Spent $3.9B In 2020 On Talc-Related Litigation
NEW BRUNSWICK, N.J. — Johnson & Johnson’s talc-related reserves and settlements were the largest driver of the company’s health care segment’s litigation expenses, which rose to $3.9 billion in 2020 compared...To view the full article, register now.
Already a subscriber? Click here to view full article